...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.
【24h】

Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.

机译:抗体反应的非人类乳头瘤病毒16型在接种疫苗单价和四价的L1病毒样粒子的疫苗。

获取原文
获取原文并翻译 | 示例
           

摘要

The incorporation of multiple antigens into a single human papillomavirus (HPV) vaccine may induce immune interference. To evaluate whether interference occurs when HPV type 16 (HPV16) virus-like particles are combined in a multivalent vaccine, we conducted a study to evaluate anti-HPV16 responses among subjects receiving three-dose regimens of either a monovalent HPV16 vaccine or a quadrivalent HPV (types 6, 11, 16, and 18) vaccine.
机译:多个抗原的结合成一个单一的人类乳头状瘤病毒(HPV)疫苗诱导免疫干扰。干涉发生在人乳头状瘤病毒16型(HPV16)病毒样颗粒结合多价疫苗,我们进行了一项研究评估anti-HPV16响应对象之一一个接收three-dose方案单价HPV16疫苗或四价的人乳头状瘤病毒(类型6、11、16和18)疫苗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号